8th November, 2017

In order to ensure that the 3D printing production of medical equipment is scientific, safe and effective, and to uphold consumer protection, the Taiwanese Food and Drug Administration (TFDA) commissioned the national Cheng Kung University to develop a draft of "the product management guideline for 3D printing medical device,” which is applicable to medical devices which use 3D printing technology in their manufacturing process. The industry can refer to this guideline and prepare the relevant documents during the product manufacturing and registration. TFDA will be holding a conference for the public to host the exchange of discussions in early November. If you are interested in this conference, you are welcome to participate!

Date: November 8th, 2017 (Wednesday)

Online Registration: https://goo.gl/2Fdhti